This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
| |
The Cancer Letter
The Blue Ribbon Panel — a group of experts selected to identify scientific opportunities for the National Cancer Moonshot Initiative — has submitted 10 recommendations to the National Cancer Advisory Board.
The panel proposes creating tumor atlases and national networks for patient engagement, immunotherapy clinical trials and data sharing. Recommendations also include supporting research on drug resistance, fusion oncoproteins, symptom management and development of cancer technologies.
READ MORE
Modern Healthcare
A lack of evidence to support the safety and efficacy of over-the-counter, antibacterial soaps was at the heart of recent rule changes that federal regulators have sought for three years.
The U.S. Food and Drug Administration issued its final rule that essentially bans companies from being able to market antiseptic wash products that contain any of 19 active ingredients out of concern that long-term daily use could pose a number of health risks. The one-time costs of the rule change are projected to be between $106.3 million and $402.8 million, the FDA said.
READ MORE
|
Promoted by
|
|
|
|
 |
CoC - NAPBC
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage you to promote Breast Cancer Awareness Month and use it as an opportunity to display and publicize your program's accreditation status with the CoC and NAPBC.
The NAPBC and the CoC have created a poster to use within your program and community.
How to access the poster:
Programs that are accredited solely by the NAPBC, use the Marketing Resources website link that was provided in your performance report email notification.
Programs that are accredited solely by the CoC or both the CoC and NAPBC, go to CoC Datalinks and click on Marketing Resources.
Please let us know about your celebration by sending photos and event information to Susan Rubin, business development manager, ACS Cancer Programs.
READ MORE
The Guardian
Top U.S. cancer scientists have urged the Obama administration to create a national cancer database for clinicians and patients as part of a slew of recommendations presented recently by the White House-supported cancer "moonshot" panel. Vice President Joe Biden assembled the scientists as part of the administration's effort to make the U.S. the country that cures cancer "once and for all."
The Cancer Moonshot Blue Ribbon Panel report said the recommendations, if implemented, "will transform our understanding of cancer and result in new opportunities to more effectively prevent and treat the disease."
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
The AJCC announces five disease site webinars that are scheduled for summer and early fall this year. The webinars, offered at no cost, will provide highlights of the five most common site chapters for AJCC seventh edition staging and include: Melanoma, Lung, Breast, Colorectum and Prostate. There will be pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
Each lecture will contain the following topics:
Overview and Learning Objectives
Anatomy Affecting Stage
Classification Issues
Assigning T, N, M, Stage Group
Information and Questions on AJCC Staging and Summary
Melanoma and Breast are now available as recordings on the AJCC website. The fifth webinar (Prostate) will be held on Sept. 21. All the webinars will be recorded for anyone who is not able to attend the live session. Register now.
You can visit the AJCC website to learn more about the Disease Site webinars and stay informed.
READ MORE
The Wall Street Journal
A new class of drugs could be a significant step forward in the treatment of ovarian cancer, one of the most lethal forms of the disease.
The drugs, known as PARP inhibitors, are thought to help the body slow the disease's progression by helping to prevent cancer cells from repairing themselves after chemotherapy treatment, thereby shrinking tumors and delaying relapses.
READ MORE
|
Promoted by
|
|
|
|
 |
The Kansas City Star
While doctors are reporting success combating several types of cancer through different versions of immunotherapy, KU clinicians say some of the most remarkable stories are arising in the treatment of blood cancers.
Deadly forms of leukemia and lymphoma, which commonly target young adults, are now being managed and in many cases vanquished using treatments unavailable just a few years ago.
READ MORE
OncLive
Given how common cancer is within the Medicare population, Medicare pays for a large percentage of oncologic care. As the population ages, both incidence and prevalence of cancer in Medicare beneficiaries will increase — and so will the cost. It's clear that Medicare needs a proactive cancer strategy, hence the launch of the Oncology Care Model.
READ MORE
FDA
The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The agency is especially concerned about delaying effective preventive treatments for women who show no symptoms, but who are still at increased risk for developing ovarian cancer.
READ MORE
With this issue, we continue our three-part series focusing on the surgical management of patients with liver disease and liver injuries. The current issue of Selected Readings in General Surgery (SRGS®) examines:
- Liver Injuries
- Contemporary Operative Management of Liver Injuries
- Cystic Disease of the Liver
- Liver Abscesses
- Benign Liver Tumors
- Liver Tumors in Children
- Liver Metastases
SRGS®, published by the American College of Surgeons (ACS) Division of Education, is an economical way to stay current with the latest and most vital surgical literature, improve patient outcomes with a state-of-the-art surgical practice, and earn up to 80 hours of CME Self-Assessment Credit. Annual subscriptions and back issues (back issues cannot be used to earn CME Credit) are available. Digital edition files, optimized for iPhone, iPad, and Kindle devices, are also available to subscribers.
If you are not currently an SRGS® subscriber, please sign up today for a free 30-day trial subscription of SRGS® Premium. To purchase a subscription, order online or call 1-800-631-0033.
READ MORE
Oncology Times
For women with early-stage breast cancer, community-based breast conserving therapy with lumpectomy plus radiation provided better survival than the national average for other available treatment options, researchers report.
Most multicenter clinical trials, especially those conducted at academic cancer centers, have shown that breast-conserving therapy and mastectomy have comparable overall survival rates in early-stage breast cancer.
READ MORE
Congratulations to the 20 Commission on Cancer (CoC)-accredited cancer programs that earned the Outstanding Achievement Award (OAA). These recipients represent cancer programs that were surveyed from Jan. 1 through June 30. Eligible OAA programs surveyed from July 1 through Dec. 31 will be announced in early 2017.
READ MORE
HealthDay
Starting palliative care shortly after a person is diagnosed with incurable cancer helps patients cope and improves their quality of life, a new study shows.
It also leads to more discussions about patients' end-of-life care preferences, the researchers added. Palliative care, also called comfort care, is given to improve the quality of life for patients who have a life-threatening disease or terminal illness, such as cancer. The goal is not to cure the patient, but to manage the symptoms of the disease, according to the U.S. National Cancer Institute.
READ MORE
AJCC
If you are attending Clinical Congress, don't miss the ACS Theatre session on the new AJCC Cancer Staging Manual, Eighth Edition. The New AJCC TNM Staging System: Vision, What's New, and Preparing for Implementation will be presented by Editor-in-Chief Mahul Amin, MD, FCAP, who will provide an overview of the staging changes that go into effect Jan. 1, 2017. His presentation will cover the new staging systems, unique paradigms for existing systems, updated General Staging rules, prognostic factors and AJCC-endorsed risk-assessment models. The presentation will be on Tuesday, Oct. 18 from 11:15 to 11:40 a.m. at the Theatre in the Exhibit Hall.
The AJCC Cancer Staging Manual, Eighth Edition, is scheduled for release at the end of October 2016.
READ MORE
Medical Xpress
An international team including Rice University researchers has discovered a way to fight the overexpression of a protein associated with the proliferation of breast cancer.
Dialing down the level of the protein NAF-1 and the activity of the iron-sulfur clusters it transports may be key to halting tumor growth, they reported.
READ MORE
OncLive
Vaginal brachytherapy (VB) has been linked to improved survival in women with stage I endometrioid adenocarcinoma of the uterus, according to a large database analysis published in Cancer.
Compared with patients who received no form of radiotherapy (RT), adjuvant VB was associated with a 19 and 38 percent reduction in the risk of death in women with stage IA and stage IB disease, respectively. It was also discovered that use of vaginal brachytherapy was not consistent with guideline recommendations.
READ MORE
CoC
The Commission on Cancer is hosting a paper competition for physicians-in-training to foster the importance of oncologic research in support of its mission. Papers are due June 30.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
